HomeTOVX • NYSEAMERICAN
add
Theriva Biologics Inc
Previous close
$0.54
Day range
$0.53 - $0.56
Year range
$0.47 - $10.75
Market cap
4.58M USD
Avg Volume
1.77M
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.42M | -18.08% |
Net income | -4.32M | 16.28% |
Net profit margin | — | — |
Earnings per share | -1.55 | 79.33% |
EBITDA | -4.39M | 17.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.01M | -45.16% |
Total assets | 32.16M | -34.00% |
Total liabilities | 16.66M | 14.08% |
Total equity | 15.50M | — |
Shares outstanding | 8.19M | — |
Price to book | 0.10 | — |
Return on assets | -32.71% | — |
Return on capital | -56.65% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.32M | 16.28% |
Cash from operations | -4.76M | 2.56% |
Cash from investing | — | — |
Cash from financing | 3.07M | — |
Net change in cash | -1.59M | 67.66% |
Free cash flow | 19.38K | 100.63% |
About
Founded
1986
Headquarters
Website
Employees
22
